chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report was received from an administrator referring to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not provided. On 03-FEB-2005, the patient was vaccinated with M-M-R II (strength, dose, dose number, route, lot # and expiration date were not reported) for prophylaxis. On 14-SEP-2018, the patient was vaccinated with VARIVAX (strength, dose detail, route, lot # and expiration date were not reported) for prophylaxis. Within one month interval with varicella VARIVAX, on 11-OCT-2018, the patient was vaccinated with another dose of M-M-R II (dose detail, route, lot # and expiration date were not reported) (inappropriate schedule of product administration). As it reported, the patient received another VARIVAX (dose detail, route, lot # and expiration date were not reported) on 15-OCT-2018. No adverse symptoms were reported.
2/9/19 - complaining of being cold 2/13/19 - hands cold, right hand more than left; skin pale/white.  fatigue 2/16/19 - 101.9 temperature, severe headache, nausea, hallucinations, eyes hurt - right more than left, sensitive to light, drowsy, agitated, stiff neck 2/17/19 - sensitive to light, headache, eye pain improving, neck not stiff, nausea subsiding, low fever, fatigue, some hallucinations 2/18/19 - improving 2/20/19 - not cold anymore, dry, chapped skin, palpable lymph nodes on neck 2/23/19 - tenderness in parotid area, skin and lips extremely chapped and dry 2/24/19 - TMJ or parotid pain, tight jaw muscles, slight difficulty swallowing 2/25/19 - TMJ pain mostly right side, hands pale and mottled 2/27/19 - fatigue 3/3/19 - trouble sleeping, neck pain, sore jaw 3/5/19 - right wrist pain, right arm pain, right side jaw pain 3/6/19 - lips and face still dry, same pain in right arm, wrist, jaw 3/7-13/19 - right arm, wrist very painful, jaw pain both sides.  Symptoms began resolving by 3/13 3/13/19 to 2/8/20 - has had four or five debilitating migraine headaches with the usual migraine symptoms, which he has never had prior to MMR
Moderna Lot # 048F21A expired on 01/22/22. This lot number was administered to the patient on 01/24/22.; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna Lot # 048F21A expired on 01/22/22. This lot number was administered to the patient on 01/24/22.) in a 19-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048F21A) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Jan-2022 at 10:00 AM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 24-Jan-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna Lot # 048F21A expired on 01/22/22. This lot number was administered to the patient on 01/24/22.). On 24-Jan-2022, EXPIRED PRODUCT ADMINISTERED (Moderna Lot # 048F21A expired on 01/22/22. This lot number was administered to the patient on 01/24/22.) had resolved. Not applicable      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported by the reporter.  No treatment medication was reported by the reporter
Maculopapular rash varying 3mm to 20mm no vesicles. Fussiness, poor appetite. Treated with BenadrylElivir 12.5mg/5ml.
Moderna COVID-19 Vaccine EUA Had chills during night. Took Naproxen with some relief. 12N had uncontrolted shaking and chills and malaise, unable to handle mouse to do work. No redness, swelling or irritation of injection site. Extremely tired.
mom stated pt had rash, itching skin, hot to touch Saturday <24 hr p/vax cont thru 5MAR95 w/no report; c/o difficulty swallowing to ER for tx; cont thru 6MAR95;
10:00pm - fever & crying (TYLENOL, .4 x .8 alternated every 4 hrs.).  1:00pm screaming - 101.3 fever with TYLENOL given.  Gave bath - did sleep in swing - fussy afterwards.  Better following day - fever down just fussy.
Dizziness & Headache Narrative: Breakthrough. Tested positive for COVID19 ON 7/31/2021
Chills; fever; This is a spontaneous report received from non-contactable reporter(s) (Consumer or other non HCP) from a sales representative. The reporter is the patient.  A patient (no qualifiers provided) received BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: CHILLS (non-serious), outcome "unknown"; PYREXIA (non-serious), outcome "unknown", described as "fever".  Additional information: Patient reported mild fever and chills for less than 24 hours after bivalent. Stated symptoms were less than with initial COVID-19 vaccine and previous booster. Event took place after use of product.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
1 hr post vaccination became listless. On 2/3/2013 ran temp of 100 degrees in AM per father. In PM had a seizure was taken by ambulance to hospital and subsequently airlifted to another hospital. Spiked temp of 106 degrees.
Racing heart - 48 hour monitor showed no events, fatigue - blood test showed no adverse effects, kidney - acute kidney disease. none of the health care providers can find a solution.
Information has been received from a certified medical assistant concerning a 24 year old female that works in the same office On 05-FEB-2007, the patient was vaccinated with a first dose of HPV. There were no concomitant medications. On 06-FEB-2007 the patient developed severe nausea, vomiting and chills. Unspecified medical attention was sought. At the time of the reporter, the patient's outcome was unknown. Additional information has been requested.
Pain in right axillary area and right side of breast a little over 24 hours after vaccine.  Pain and swelling caused moderate discomfort about 6 on 1-10 scale and then by day 5 minimal pain just uncomfortable to sleep on that side
Patient said area was swollen, sore, itching, numb. Facial swelling.
Tremors continued with the same intensity after subsequent shots; First dose on 20JAN2021 and 2nd shot on 07FEB2021; This spontaneous case was reported by a patient and describes the occurrence of TREMOR (Tremors continued with the same intensity after subsequent shots) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First dose on 20JAN2021 and 2nd shot on 07FEB2021) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032120A and 0391-2A) for COVID-19 vaccination.     Family history included Parkinson's disease (Father had Parkinson's disease) since an unknown date. Concomitant products included PIROXICAM (PAXIL [PIROXICAM]) and ATORVASTATIN for an unknown indication.   On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 07-Feb-2021, the patient experienced TREMOR (Tremors continued with the same intensity after subsequent shots) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First dose on 20JAN2021 and 2nd shot on 07FEB2021). The patient was treated with PRIMIDONE for Prevention, at an unspecified dose and frequency. At the time of the report, TREMOR (Tremors continued with the same intensity after subsequent shots) had not resolved and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First dose on 20JAN2021 and 2nd shot on 07FEB2021) outcome was unknown.            After the very first primary shot, patient started having tremors, and her nervous System was affected. She stated that the tremors never went away. It continued with the same intensity after subsequent shots.  Recently she was diagnosed with Parkinson's Disease, but not started on any medications.  Primidone did not help for tremors.   This case was linked to MOD-2022-572262, MOD-2022-572193, MOD-2022-572261 (Patient Link).
I was dizzy and rapid heartbeat after the injection but not bad enough for care. That receded after an hour or so, but then I had the worst herpes nerve pain down my legs that I've ever had. Took the acyclovir and mostly avoided the breakout, but felt bad for a few days. No fever. A week after the vaccination I started to feel dizzy on and off then 10 days or so later started having weird heart palpitations and pressure in my chest. I ended up in the ER. They said I wasn't having a heart attack but the condition has continued on and off as well as the dizziness. I also got a period 3 weeks after the shot having not had one for almost 2 years. I'm still not feeling well 4 weeks after the 1st shot with fatigue, intermittent dizziness and heart issues. I've been advised to hold off on the second shot. The dizziness was diagnosed as vertigo.
Vaccine was expired on 04-Apr-2022 then stored in refrigerator on same date of administration; Vaccine was expired on 04-Apr-2022 and administered on 16-Apr-2022; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine was expired on 04-Apr-2022 and administered on 16-Apr-2022) and PRODUCT STORAGE ERROR (Vaccine was expired on 04-Apr-2022 then stored in refrigerator on same date of administration) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 066H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Apr-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine was expired on 04-Apr-2022 and administered on 16-Apr-2022). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine was expired on 04-Apr-2022 then stored in refrigerator on same date of administration). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine was expired on 04-Apr-2022 and administered on 16-Apr-2022) and PRODUCT STORAGE ERROR (Vaccine was expired on 04-Apr-2022 then stored in refrigerator on same date of administration) outcome was unknown. Not provided.      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The patient weight had been reported as 232. No concomitant medications were reported. The HCP (health care professional) stated that they had administered an expired doses of the Moderna COVID-19 Vaccine to 27 patients. The date of the vial that was initially stored in the refrigerator was the same day when the vials were thawed. The vial had not undergone any temperature excursions. The patient had no known reactions at office. No treatment information was provided.
The next day i began to get a rash on my body. Each day it got worse & all over my body. Itchier every day.Itd been 9 dys & i still have it.; This is a spontaneous report from a contactable consumer, the patient. A 72-Year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER- BIONTECH COVID-19 mRNA Vaccine; Lot Number: En6205), via an unspecified route of administration in the arm left on 15Mar2021 at 12:30 (at the age of 72-years-old), as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included liothyronine (MANUFACTURER UNKNOWN), levothyroxine (MANUFACTURER UNKNOWN), strontium (MANUFACTURER UNKNOWN), b12 (MANUFACTURER UNKNOWN) and D3 (MANUFACTURER UNKNOWN) given for an unknown indication from an unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. After the vaccination, on 16Mar2021 at 09:30 the patient began to experience rash on the body. Each day it got worse & experienced all over the body. It had been 9 days & still it is continuing. The events did not result in doctor or other healthcare professional office/clinic visit. The patient received prednisone for 5 days, BENADRYL and hydrocortisone (MANUFACTURER UNKNOWN) for the event rash. The clinical outcome of the event rash was not recovered at the time of this report.   No follow-up attempts are needed. No further information was expected.
Pt received wrong dosage of Pfizer. Pt was 12 years old and received Pedi dosage (0.2) of Pfizer. During  the registration dad was unsure the year of birth for the patient. After the pt received his vaccination dad then realized the child was born in 2009, and that he had given the wrong age to the nurse, Dad was aware of the incident and understood what had happened with the child getting vaccinated. The nurse also educated the parent on the age difference for the doses of Pfizer
Several weeks since 2nd vaccine have had left neck pain and left inner knee pain; Several weeks since 2nd vaccine have had left neck pain and left inner knee pain; This is a spontaneous report from a contactable consumer, the patient. A 62-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the left arm on 05Apr2021 at 08:30 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient did not have allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included multi vitamin (MANUFACTURER UNKNOWN) for an unknown indication from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the left arm on 15Mar2021 at 08:30 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. On 06Apr2021 at 05:00, several weeks since 2nd vaccine, the patient experienced left neck pain and left inner knee pain on daily and she did not normally experience these pains. She responded well to ibuprofen. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events left neck pain and left inner knee pain was resolving at the time of this report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
This spontaneous report as received from a physician refers to a 15 or 16 years old female patient. The patient's relevant medical history, concurrent conditions and concomitant medications were not reported. On an unknown date approximately in January 2016 (also reported as one and one half to two years ago), the patient was vaccinated with an unspecified dose of GARDASIL (dosing details were not reported), intramuscularly for prophylaxis or GARDASIL 9 (dosing details were not reported) intramuscularly for prophylaxis (unidentified Merck hpv vaccine administered). It could not be confirmed if the patient had been administered GARDASIL or GARDASIL 9. The patient experienced a headache for one month after being administered the GARDASIL or GARDASIL 9 vaccine. The patient did seek medical attention, but the route by which the patient sought medical attention could not be confirmed. The outcome of headache was unknown. Causality assessment was not reported. No product quality complaint involved.
This spontaneous case was reported by an other health care professional and describes the occurrence of FLUSHING (Flushing from head to toe), PRESYNCOPE (Vasovagal response), HEART RATE INCREASED (High heart rate), DIZZINESS (dizziness) and PAIN IN EXTREMITY (Sore arm) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011L20A and 030L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No medical history was provided by the reporter.  Concomitant products included VITAMIN D3 for an unknown indication. On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 06-Jan-2021, the patient experienced FLUSHING (Flushing from head to toe), PRESYNCOPE (Vasovagal response), HEART RATE INCREASED (High heart rate), DIZZINESS (dizziness), PAIN IN EXTREMITY (Sore arm) and PERIPHERAL SWELLING (Swollen arm). On 05-Feb-2021, the patient experienced ERYTHEMA (Whole neck and upper chest was red), HEAD DISCOMFORT (Rush of pressure into my head), HYPERTENSION (High blood pressure), VEIN DISORDER (Vein sensation) and FLUSHING (Flushing within 1-2 mins). At the time of the report, FLUSHING (Flushing from head to toe), PRESYNCOPE (Vasovagal response), HEART RATE INCREASED (High heart rate), DIZZINESS (dizziness), PAIN IN EXTREMITY (Sore arm), PERIPHERAL SWELLING (Swollen arm), ERYTHEMA (Whole neck and upper chest was red), HEAD DISCOMFORT (Rush of pressure into my head), HYPERTENSION (High blood pressure), VEIN DISORDER (Vein sensation) and FLUSHING (Flushing within 1-2 mins) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No treatment information provided.
74 year old male received the 1st dose of the Moderna COVID-19 vaccine on 03/05/2021 @ 12:00. On 04/01/2021 pt had fever and displayed flu like symptoms. Pt went to primary doctor that day 04/01/0221, doctor placed pt on ciprofloxacin and APAP. Symptoms resolved by 04/03/2021. Pt takes metformin and ezetimibe. Pt is diagnosed with diabetes and dyslipidemia. Pt denies allergies. Pt asked if the second dose was advised. Pt was instructed to get the second dose of the Moderna vaccine and to tell the facility of your reaction to the first dose and the possibility of staying longer in observation after the second dose.
Patient describes muscle pain lasting longer than 1 month. He says that he works out and has tried to continued to exercise through the pain but it has not improved.
She says that this is the first time after receiving immunizations that she experienced an adverse event. Patient states that she noticed nothing on Friday (9/29/2017) after receiving immunizations. She awoke Saturday (9/30/2017) morning with a very painful right shoulder and fever of 102.5 taken orally with digital thermometer that broke later in the evening. She took ibuprofen throughout the day and evening Saturday. On Sunday (10/01/2017) she awoke and fever came back at 101.7 taken orally with digital thermometer and broke again in evening. She took ibuprofen throughout the day and evening Sunday. Her shoulder was still painful, but getting better. Today (10/02/2017), she has not checked her temperature, but does not feel that she has fever. She states that she is "feeling better now", but that her right shoulder is still sore. She has not taken any ibuprofen today. Denies erythema, but states that skin on right shoulder was hot to touch. Denies ecchymosis.
Patient presented to the ED and was subsequently hospitalized within 6 weeks of receiving COVID Vaccination.
I itch & have rash on random location on my body that last about 20-30 minutes. This happens 5-10 times a day.
coughed clots of blood; her head started to hurt from thinking about what happened; After it happened, when she started to cough blood, it has not occurred again. Caller previously stated the condition had worsened; threw blood; describes it as a blood clot; This is a spontaneous report from a contactable consumer (patient).  A 55-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration, administered in arm left on 02Aug2021 10:00 (Lot Number: EW0180) at the age of 55-year-old as single dose for covid-19 immunisation.  Medical history included covid-19 and cough.  Prior vaccinations, no other vaccinations within four weeks prior to the first administration was taken. There was no family medical history relevant to events. No relevant tests were done. The patient's concomitant medications were not reported. Caller received the first dose of the Pfizer Covid-19 vaccine on Monday 02Aug2021, before she got the vaccine he told the vaccine administrator that she had had Covid-19 and as a consequence still had cough so she asked if she could get the vaccine and they said yes, from time to time she coughs, it is not very often but when it happens it hits her strong and coughs phlegm. She usually coughs, but today, the cough has blood in it.  She coughed up clotted blood.  About 10 minutes ago she coughed but instead of expelling phlegm, she threw blood, she describes it as a blood clot in Aug2021, she didn't know if it was because of the coughing effort, she would like to know if this may be due to the vaccine. She also mentioned that after this her head started to hurt from thinking about what happened on 05Aug2021. It happened 10 minutes ago. Patient confirmed information above.  Instead of phlegm, she coughed clots of blood on 05Aug2021. She had been coughing the whole time before she got the shot.  After it happened, when she started to cough blood, it has not occurred again. Caller previously stated the condition had worsened in Aug2021. She was not on any medication.  She only took paracetamol (TYLENOL) for the pain.  These events did not require emergency room or physician office.  She was going to call the clinic to see if she can be checked, but had not been yet.  Outcome of coughed clots of blood and when she started to cough blood, it has not occurred again/previously stated the condition worsened was not recovered, of other events was unknown.   Follow-up attempts are completed. No further information is expected.
PREVNAR 13 was given on Nov 17th, 1. Traveled by plane on Nov 18th, (9 hours) no sick contacts per report. 2. Nov 19th lack of fluid, mouth dry, drank water only, Felt cold and no appetite. 3. Friday the 20th in am, was at gluten free deli, continues with no appetite generalized myalgia, no injection site problems noted. but feverish 3:00pm with temp 103, spouse was not sick, throughout the day (felt fatigue, sleepy), took 200mg Aleve, drinking herbal tea. 4. Nov 21st 5 water stools, with myalgia continues, injection site soreness without erythematous, but appetite return and grandchildren with some URI symptoms but not new. 5. Site soreness resolved Nov 23rd, then croupy cough started, (did not take any OTC meds). 6. Returned by plane Nov 28th with loss of voice, coughing, no current meds, Currently takes some TEA Virubamax (herbal), doing organic bullion. Voice cracking today (12/4/15), multidextrin in herbal tea which she has allergy to. ASSESSMENT/PLAN: (12/4/15) 1. Laryngitis ongoing. will start on prednisone 10mg po daily x 5 days only. Will fill out Vaccine adverse even reporting system as seems the patient was exposed to multiple viruses during travel explaining symptoms, however the process of injection prior to all the symptoms warrants reporting. fever 103, fatigue, myalgia, diarrhea resolved, loss of appetite resolved voice changes (ongoing issues) documented per patient. reviewed all adverse problems on handout.
The patient is a 16 y.o. male with a past medical history significant for anxiety, depression, and evaluation twice in the past month in the ED/urgent care for drug ingestion. Admitted on 2/4/22  for the primary encounter diagnosis was Methamphetamine intoxication (*). A diagnosis of Purposeful non-suicidal drug ingestion,
BP 153/89, HR 84,O2 100%, 12 lead normal.  Anxiety, weakness, palpitations. Exit time 11:22 am.